IDO1 and cervical carcinoma: Importantly, cervical cancer expresses one of the highest amounts of IDO (20–22), and both IL-6 and IDO are negative prognostic markers in patients diagnosed with this neoplasm (8, 23), highlighting the IDO/IL6 axis as an important self-immunoregulatory network in cervical cancer.